Developer docs
API playgroundTry for free, no card

Search company profiles

Scale Biosciences

Full company profile

uuid0003xi5

Namestring
Scale Biosciences
Legal namestring
Scale Biosciences, Inc.
Websiteurl
scale.bio
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Scale Biosciences is a privately held biotechnology company headquartered in San Diego, California, founded in 2020-2021 by a group of four scientific co-founders — Garry Nolan, Frank Steemers, Jay Shendure, and Cole Trapnell — and led by CEO Giovanna Prout. The company develops single cell library preparation kits and supporting analytical software for genomic, transcriptomic, and epigenomic profiling, with a core focus on enabling large-cohort, statistically powered single cell studies that have been cost-prohibitive under incumbent droplet-based technologies.

Scale Bio's product portfolio is anchored by its proprietary Quantum Barcoding platform, which consolidates multiple levels of combinatorial barcoding into a single streamlined workflow and reportedly supports over 675 million unique barcode combinations. The commercial offering spans three configurations of the QuantumScale Single Cell RNA kit (Medium at 168K cells, Large at 2M cells, Extra Large at 4M cells), the ScalePlex sample multiplexing system (capable of pooling over 9,000 samples per run), the Single Cell Methylation Kit v1.1 (positioned as the first commercial single cell DNA methylation solution), the CRISPR Guide Enrichment Kit for pooled CRISPR screening at single cell resolution, and the SeqSuite bioinformatics analysis pipeline (with Seurat-compatible outputs). The platform operates without a dedicated instrument, processing fixed samples into sequencer-ready libraries in approximately 1.5 days, and is validated on Illumina NovaSeq X, NextSeq, and Ultima Genomics UG 100 sequencers.

The company generates revenue through one-time sales of reagent kits (RNA, methylation, CRISPR, ScalePlex fixation), with pricing set on a quote basis (no public list price) and unit economics reported at less than one cent per cell and under $100 per sample at scale. Distribution combines direct enterprise sales (web-driven quote requests) with a regional distributor channel covering EMEA and APAC through partnerships with entities such as 3 Genes, Lifegene, CARLO ERBA Reagents, Altium, Proquinorte, Gulf Scientific Corporation, Integrated Sciences, BioStream, LNC Bio, and Genomax Technologies. Primary end customers are academic research institutions and pharmaceutical/biotech drug discovery groups, with named users including Yale University, Vanderbilt University Medical Center, UCLA, Albert Einstein College of Medicine, OHSU Knight Cancer Institute, Princess Margaret Cancer Centre, and the University of Miami. The company is also a participant in the Chan Zuckerberg Initiative's Billion Cells Project and a collaborator with NVIDIA and Ultima Genomics on the 100 Million Cells Initiative. On August 7, 2025, 10x Genomics announced an agreement to acquire Scale Biosciences to integrate the Quantum Barcoding technology into its Chromium platform.

Short descriptiontext

Scale Biosciences is a San Diego-based private biotechnology company that develops Quantum Barcoding-powered single cell library preparation kits — including RNA, methylation, and CRISPR screening products — for academic research institutions and pharmaceutical/biotech customers, generating revenue through direct reagent kit sales and a global distributor network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
single cell RNA sequencing, single cell methylation kits, CRISPR screening reagents, sample multiplexing kits, epigenetics research tools
Industry5 codes
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGANAF
Epigenomics & Chromatin Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAIAG
CRISPR & Functional Genomics Screening Platforms (pooled/arrayed screens, perturb-seq)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAMAJ
Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Life Science Research Tools
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Single Cell RNA Sequencing Kits
TypeOne Time License
Description

Sale of QuantumScale Single Cell RNA kits in multiple sizes (Medium, Large, Extra Large) enabling 168K to 4M cells per run. One-time purchase of reagent kits with no instrument required.

scale.bio
2Single Cell Methylation Kits
TypeOne Time License
Description

Sale of Single Cell Methylation Kit v1.1 for detecting single cell DNA methylation states. Optional target enrichment add-on for focused sequencing.

scale.bio
3ScalePlex Fixation Kits
TypeOne Time License
Description

Specialized fixation kits with integrated oligo barcodes for streamlined sample multiplexing. Available in Small and Large configurations.

scale.bio
4CRISPR Guide Enrichment Kits
TypeOne Time License
Description

Kits for high-throughput CRISPR screening at single cell resolution, with optional Extended Throughput versions.

scale.bio
5Services
TypeProfessional Services
Description

Service lab offerings for customers who want to outsource single cell project execution. Comprehensive services for projects large and small.

scale.bio
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details3 tiers
1QuantumScale Small Kit - 168K cells
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Entry-level kit for standard-sized projects including biobanked specimens and time-course studies. 16 samples at 10k cells/sample. Pricing quoted upon request.

scale.bio
2QuantumScale Medium Kit - 2M cells
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Mid-tier kit for drug perturbation projects, population and cohort studies, and AI foundation models. 200 samples at 10k cells/sample. Pricing quoted upon request.

scale.bio
3QuantumScale Extra Large Kit - 4M cells
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Maximum throughput kit for large-scale projects. 400 samples at 10k cells/sample. Compatible with NovaSeq X 25B and UG 100 flow cells. Pricing quoted upon request.

scale.bio
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1QuantumScale
Description

QuantumScale Single Cell RNA is powering the next generation of single cell with one flexible platform to meet any scale and research vision, processing from 168,000 to 4 million cells.

scale.bio
+4 more records
Core offering1 text field

Scale Biosciences develops and sells reagent kits and laboratory services for single cell genomic, transcriptomic, and epigenomic profiling, powered by its proprietary Quantum Barcoding technology. The portfolio includes the QuantumScale Single Cell RNA kit family (processing 168K to 4M cells per run), the Single Cell Methylation Kit for DNA methylation analysis, the ScalePlex sample multiplexing reagents, and the CRISPR Guide Enrichment Kit for pooled CRISPR screening at single cell resolution.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 75% reduction in hands-on time compared to other single cell workflows
+6 more records
Product overview1 text field

Scale Biosciences offers a portfolio of single cell analysis products centered around its proprietary Quantum Barcoding technology. The core offerings include the QuantumScale Single Cell RNA platform (available in Medium, Large, and Extra Large kit sizes), the Single Cell Methylation Kit for epigenetics research, and the CRISPR Guide Enrichment Kit. The platform is complemented by ScalePlex sample multiplexing technology, the SeqSuite bioinformatics analysis pipeline, and laboratory services. Products range from small-scale studies (168K cells) to massive projects (4 million cells), targeting researchers across oncology, immunology, neuroscience, cell atlasing, drug development, and developmental biology.

Product and service6 records
1QuantumScale Single Cell RNA
CategoryReagent Kits
2Single Cell Methylation Kit
CategoryReagent Kits
3ScalePlex Multiplexing Kit
4CRISPR Guide Enrichment Kit
CategoryReagent Kits
5SeqSuite Bioinformatics Pipeline
CategoryBioinformatics Software
6Single Cell Product Services
CategoryLaboratory Services
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-10-16
Description

10x Genomics announced acquisition of Scale Biosciences in August 2025 to expand its single cell analysis capabilities. The acquisition aims to integrate Scale's innovations into 10x's Chromium platform to improve accessibility and scientific breakthroughs. Note: Despite acquisition announcement, Scale Bio continues to operate and ship products independently.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Scale Bio joined CZI's Billion Cells Project alongside technology partners 10x Genomics and Ultima Genomics. This landmark effort aims to generate an unprecedented one billion cell dataset to fuel rapid progress in cell biology through AI model development.

Strategic tierCoreTypeTechnology or Integration
Description

Ultima Genomics is a collaborator on the 100M Cell Challenge initiative. Their UG 100 sequencer is listed as compatible with QuantumScale Single Cell RNA kits, enabling customers to run Scale Bio libraries on Ultima's platform.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nvidia is a collaborator on the 100M Cell Challenge initiative, supporting single cell research at unprecedented scale. The partnership contributes to advancing AI model development in cell biology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CZ Biohub NY is part of CZI's biohub network. Researcher John Tsang is affiliated with CZ Biohub NY and uses Scale Bio technology for large-scale single cell studies.

Strategic tierCoreTypeTechnology or Integration
Description

SPT Labtech partnered with Scale Bio to automate the Single Cell Methylation workflow using the firefly liquid handling system. This collaboration reduces processing time by 35% while maintaining high-quality results, expanding access to advanced single cell and spatial solutions.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Czech Republic, Slovakia, and Hungary. Located at Verdunská 819/37, Bubeneč, Prague 6. Contact via info@3genes.com or +420 605 862 297.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Israel. Located in Mevo Horon, Israel. Contact via info@lifegene.co.il or +972-(0)8-6444314.

9CARLO ERBA Reagents S.r.l
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Italy. Located at via Merendi 22, 20007 Cornaredo (Milano). Contact via servizioclienticer@dgroup.it or +39 0293991003.

scale.bio
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Poland. Located at Puławska 303, 02-785 Warsaw. Contact via bio@perlan.com.pl or +48 22 549 14 00.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Portugal and Spain. Located at Parque Tecnologico 208, 48170 Zamudio. Contact via info@proquinorte.com or +34 900 900 942.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for UAE, KSA, Kuwait, Bahrain, Oman, and Qatar. UAE office at Dubai Investment Park 2, Dubai. Additional offices in Saudi Arabia (Riyadh), Kuwait, Bahrain, and Oman. Contact via info@gulf-scientific.com or +971 4 881 5270.

13Integrated Sciences
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Australia and New Zealand. Located at 54 Gibbes Street, Chatswood, NSW 2064, Australia. Contact via tech@integratedsci.com.au or +61 2 9417 7866.

scale.bio
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Japan. Located at Showa Astec Bldg No.1, 2-7-3 Higashi Shinbashi, Minato-Ku, Tokyo 105-0021. Contact via info@biostream.co.jp or +81-3-6869-4402.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for South Korea. Located at 12F, 275, Gangnam-daero, Seocho-gu, Seoul, Republic of Korea, 06729. Contact via info@lncbio.com or +82 2-3472-0370.

Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor for Singapore, Malaysia, and Thailand. Singapore office at 237 Pandan Loop, #06-03 Westech Building 128424. Malaysia office at Puchong, Selangor. Thailand office at Mercury Tower, 8th Floor, Room 802, Bangkok. Contact via info@genomax.com.sg or +65 6777 1886.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Parse Biosciences offers single-cell sequencing kits based on combinatorial indexing barcoding chemistry that enables large-scale profiling without proprietary instruments — directly comparable to Scale Bio's Quantum Barcoding approach. Parse has actively litigated against Scale Bio over barcoding IP.

TypeDirect peer
Description

10x Genomics is the dominant commercial single-cell analysis company offering the Chromium platform for single-cell RNA, ATAC, and multi-omic workflows. It is the most direct competitor to Scale Bio's QuantumScale kits and is also the announced acquirer of Scale Biosciences.

TypeDirect peer
Description

BD Biosciences markets the Rhapsody single-cell analysis platform for transcriptomic and multi-omic applications, competing head-to-head with both 10x Genomics and Scale Bio in academic and pharma single-cell workflows.

TypeBroad incumbent
Description

Element Biosciences offers the AVITI sequencing platform as a lower-cost alternative to Illumina. As an alternative sequencer platform, Element is an indirect competitor to Scale Bio in shaping customers' choice of single-cell library preparation and sequencing stack.

TypeEmerging player
Description

Vizgen offers MERSCOPE spatial transcriptomics. Scale Bio and Vizgen have a documented integration partnership for combining Scale Bio's single-cell RNA with Vizgen's spatial analysis, positioning Vizgen as a complementary adjacent peer in the broader single-cell/spatial genomics market.

TypeEmerging player
Description

AtlasXomics provides single-cell ATAC-seq and multi-omic epigenomic profiling services, directly competing with Scale Bio's Single Cell Methylation Kit in the epigenomics research market.

TypeEmerging player
Description

Ultima Genomics is a sequencing platform provider whose UG 100 instrument is compatible with Scale Bio's QuantumScale kits. The companies are co-collaborators in CZI's Billion Cells Project and the 100M Cell Challenge initiative.

TypeEmerging player
Description

Fluent Biosciences offers PIP-seq, a single-cell RNA sequencing technology using combinatorial barcoding that competes with Scale Bio's QuantumScale in the no-instrument, low-cost segment of the market.

TypeBroad incumbent
Description

Illumina is the dominant sequencing platform provider whose NovaSeq and NextSeq instruments are the primary downstream readout for Scale Bio's kits. Illumina also offers its own single-cell and multi-omic library prep products, making it both a critical partner and a broad incumbent competitor.

TypeBroad incumbent
Description

Bio-Rad offers ddSEQ single-cell RNA sequencing solutions through partnership with Illumina, competing in academic and translational research single-cell workflows alongside Scale Bio and other droplet-based platforms.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Scale Biosciences

Life Science Research Toolsscale.bio

Scale Biosciences is a San Diego-based private biotechnology company that develops Quantum Barcoding-powered single cell library preparation kits — including RNA, methylation, and CRISPR screening products — for academic research institutions and pharmaceutical/biotech customers, generating revenue through direct reagent kit sales and a global distributor network.

What Scale Biosciences does

Scale Biosciences is a privately held biotechnology company headquartered in San Diego, California, founded in 2020-2021 by a group of four scientific co-founders — Garry Nolan, Frank Steemers, Jay Shendure, and Cole Trapnell — and led by CEO Giovanna Prout. The company develops single cell library preparation kits and supporting analytical software for genomic, transcriptomic, and epigenomic profiling, with a core focus on enabling large-cohort, statistically powered single cell studies that have been cost-prohibitive under incumbent droplet-based technologies.

Scale Bio's product portfolio is anchored by its proprietary Quantum Barcoding platform, which consolidates multiple levels of combinatorial barcoding into a single streamlined workflow and reportedly supports over 675 million unique barcode combinations. The commercial offering spans three configurations of the QuantumScale Single Cell RNA kit (Medium at 168K cells, Large at 2M cells, Extra Large at 4M cells), the ScalePlex sample multiplexing system (capable of pooling over 9,000 samples per run), the Single Cell Methylation Kit v1.1 (positioned as the first commercial single cell DNA methylation solution), the CRISPR Guide Enrichment Kit for pooled CRISPR screening at single cell resolution, and the SeqSuite bioinformatics analysis pipeline (with Seurat-compatible outputs). The platform operates without a dedicated instrument, processing fixed samples into sequencer-ready libraries in approximately 1.5 days, and is validated on Illumina NovaSeq X, NextSeq, and Ultima Genomics UG 100 sequencers.

The company generates revenue through one-time sales of reagent kits (RNA, methylation, CRISPR, ScalePlex fixation), with pricing set on a quote basis (no public list price) and unit economics reported at less than one cent per cell and under $100 per sample at scale. Distribution combines direct enterprise sales (web-driven quote requests) with a regional distributor channel covering EMEA and APAC through partnerships with entities such as 3 Genes, Lifegene, CARLO ERBA Reagents, Altium, Proquinorte, Gulf Scientific Corporation, Integrated Sciences, BioStream, LNC Bio, and Genomax Technologies. Primary end customers are academic research institutions and pharmaceutical/biotech drug discovery groups, with named users including Yale University, Vanderbilt University Medical Center, UCLA, Albert Einstein College of Medicine, OHSU Knight Cancer Institute, Princess Margaret Cancer Centre, and the University of Miami. The company is also a participant in the Chan Zuckerberg Initiative's Billion Cells Project and a collaborator with NVIDIA and Ultima Genomics on the 100 Million Cells Initiative. On August 7, 2025, 10x Genomics announced an agreement to acquire Scale Biosciences to integrate the Quantum Barcoding technology into its Chromium platform.

Scale Biosciences firmographics

Firmographics
Name
Scale Biosciences
Legal name
Scale Biosciences, Inc.
Website
https://scale.bio
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Scale Biosciences is a San Diego-based private biotechnology company that develops Quantum Barcoding-powered single cell library preparation kits — including RNA, methylation, and CRISPR screening products — for academic research institutions and pharmaceutical/biotech customers, generating revenue through direct reagent kit sales and a global distributor network.
Ownership category
akta.pro rank

Scale Biosciences industry classification

Industry
Product category
Life Science Research Tools
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGANAF
Epigenomics & Chromatin Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAIAG
CRISPR & Functional Genomics Screening Platforms (pooled/arrayed screens, perturb-seq)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAMAJ
Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Single cell RNA sequencing
  • Single cell methylation kits
  • CRISPR screening reagents
  • Sample multiplexing kits
  • Epigenetics research tools

Where Scale Biosciences is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Scale Biosciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Single Cell RNA Sequencing Kits: Sale of QuantumScale Single Cell RNA kits in multiple sizes (Medium, Large, Extra Large) enabling 168K to 4M cells per run. One-time purchase of reagent kits with no instrument required.
  2. Single Cell Methylation Kits: Sale of Single Cell Methylation Kit v1.1 for detecting single cell DNA methylation states. Optional target enrichment add-on for focused sequencing.
  3. ScalePlex Fixation Kits: Specialized fixation kits with integrated oligo barcodes for streamlined sample multiplexing. Available in Small and Large configurations.
  4. CRISPR Guide Enrichment Kits: Kits for high-throughput CRISPR screening at single cell resolution, with optional Extended Throughput versions.
  5. Services: Service lab offerings for customers who want to outsource single cell project execution. Comprehensive services for projects large and small.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goQuantumScale Small Kit - 168K cells
Unit PricingPay-as-you-goQuantumScale Medium Kit - 2M cells
Unit PricingPay-as-you-goQuantumScale Extra Large Kit - 4M cells

Go-to-market motion3 records

Distribution channels3 records

Marketing channels9 records

Scale Biosciences product offering

Product offering

Core offering

Scale Biosciences develops and sells reagent kits and laboratory services for single cell genomic, transcriptomic, and epigenomic profiling, powered by its proprietary Quantum Barcoding technology. The portfolio includes the QuantumScale Single Cell RNA kit family (processing 168K to 4M cells per run), the Single Cell Methylation Kit for DNA methylation analysis, the ScalePlex sample multiplexing reagents, and the CRISPR Guide Enrichment Kit for pooled CRISPR screening at single cell resolution.

Product overview

Scale Biosciences offers a portfolio of single cell analysis products centered around its proprietary Quantum Barcoding technology. The core offerings include the QuantumScale Single Cell RNA platform (available in Medium, Large, and Extra Large kit sizes), the Single Cell Methylation Kit for epigenetics research, and the CRISPR Guide Enrichment Kit. The platform is complemented by ScalePlex sample multiplexing technology, the SeqSuite bioinformatics analysis pipeline, and laboratory services. Products range from small-scale studies (168K cells) to massive projects (4 million cells), targeting researchers across oncology, immunology, neuroscience, cell atlasing, drug development, and developmental biology.

Differentiator

Problem solved

Functional benefit

Brands

  • QuantumScale: QuantumScale Single Cell RNA is powering the next generation of single cell with one flexible platform to meet any scale and research vision, processing from 168,000 to 4 million cells.
  • Single Cell Methylation Kit
  • ScalePlex
  • CRISPR Guide Enrichment Kit
  • SeqSuite

Products and services

  • QuantumScale Single Cell RNA
  • Single Cell Methylation Kit
  • ScalePlex Multiplexing Kit
  • CRISPR Guide Enrichment Kit
  • SeqSuite Bioinformatics Pipeline
  • Single Cell Product Services

Quantifiable outcome

  • 75% reduction in hands-on time compared to other single cell workflows
  • +6 more outcomes

Companies that use Scale Biosciences

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Scale Biosciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

Feature6 records

Scale Biosciences partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered flagship, core and regional.

  • 10x GenomicsflagshipStrategic or Co-development Partner · 16 October 202510x Genomics announced acquisition of Scale Biosciences in August 2025 to expand its single cell analysis capabilities. The acquisition aims to integrate Scale's innovations into 10x's Chromium platform to improve accessibility and scientific breakthroughs. Note: Despite acquisition announcement, Scale Bio continues to operate and ship products independently.
  • Chan Zuckerberg Initiative (CZI)flagshipStrategic or Co-development PartnerScale Bio joined CZI's Billion Cells Project alongside technology partners 10x Genomics and Ultima Genomics. This landmark effort aims to generate an unprecedented one billion cell dataset to fuel rapid progress in cell biology through AI model development.
  • Ultima GenomicscoreTechnology or IntegrationUltima Genomics is a collaborator on the 100M Cell Challenge initiative. Their UG 100 sequencer is listed as compatible with QuantumScale Single Cell RNA kits, enabling customers to run Scale Bio libraries on Ultima's platform.
  • NvidiacoreStrategic or Co-development PartnerNvidia is a collaborator on the 100M Cell Challenge initiative, supporting single cell research at unprecedented scale. The partnership contributes to advancing AI model development in cell biology.
  • Chan Zuckerberg Biohub NYcoreStrategic or Co-development PartnerCZ Biohub NY is part of CZI's biohub network. Researcher John Tsang is affiliated with CZ Biohub NY and uses Scale Bio technology for large-scale single cell studies.
  • SPT LabtechcoreTechnology or IntegrationSPT Labtech partnered with Scale Bio to automate the Single Cell Methylation workflow using the firefly liquid handling system. This collaboration reduces processing time by 35% while maintaining high-quality results, expanding access to advanced single cell and spatial solutions.
  • 3 Genes (BioSeq a.s.)regionalChannel Partner/ Reseller/ DistributorRegional distributor for Czech Republic, Slovakia, and Hungary. Located at Verdunská 819/37, Bubeneč, Prague 6. Contact via info@3genes.com or +420 605 862 297.
  • LifegeneregionalChannel Partner/ Reseller/ DistributorRegional distributor for Israel. Located in Mevo Horon, Israel. Contact via info@lifegene.co.il or +972-(0)8-6444314.
  • CARLO ERBA Reagents S.r.lregionalChannel Partner/ Reseller/ DistributorRegional distributor for Italy. Located at via Merendi 22, 20007 Cornaredo (Milano). Contact via servizioclienticer@dgroup.it or +39 0293991003.
  • Altium International Ltd.regionalChannel Partner/ Reseller/ DistributorRegional distributor for Poland. Located at Puławska 303, 02-785 Warsaw. Contact via bio@perlan.com.pl or +48 22 549 14 00.
  • Proquinorte S.A.regionalChannel Partner/ Reseller/ DistributorRegional distributor for Portugal and Spain. Located at Parque Tecnologico 208, 48170 Zamudio. Contact via info@proquinorte.com or +34 900 900 942.
  • Gulf Scientific CorporationregionalChannel Partner/ Reseller/ DistributorRegional distributor for UAE, KSA, Kuwait, Bahrain, Oman, and Qatar. UAE office at Dubai Investment Park 2, Dubai. Additional offices in Saudi Arabia (Riyadh), Kuwait, Bahrain, and Oman. Contact via info@gulf-scientific.com or +971 4 881 5270.
  • Integrated SciencesregionalChannel Partner/ Reseller/ DistributorRegional distributor for Australia and New Zealand. Located at 54 Gibbes Street, Chatswood, NSW 2064, Australia. Contact via tech@integratedsci.com.au or +61 2 9417 7866.
  • BioStream Co., LTD.regionalChannel Partner/ Reseller/ DistributorRegional distributor for Japan. Located at Showa Astec Bldg No.1, 2-7-3 Higashi Shinbashi, Minato-Ku, Tokyo 105-0021. Contact via info@biostream.co.jp or +81-3-6869-4402.
  • LNC BioregionalChannel Partner/ Reseller/ DistributorRegional distributor for South Korea. Located at 12F, 275, Gangnam-daero, Seocho-gu, Seoul, Republic of Korea, 06729. Contact via info@lncbio.com or +82 2-3472-0370.
  • Genomax TechnologiesregionalChannel Partner/ Reseller/ DistributorRegional distributor for Singapore, Malaysia, and Thailand. Singapore office at 237 Pandan Loop, #06-03 Westech Building 128424. Malaysia office at Puchong, Selangor. Thailand office at Mercury Tower, 8th Floor, Room 802, Bangkok. Contact via info@genomax.com.sg or +65 6777 1886.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Scale Biosciences competitors and assessment

Company assessment

Direct peers

  • Parse Biosciences: Parse Biosciences offers single-cell sequencing kits based on combinatorial indexing barcoding chemistry that enables large-scale profiling without proprietary instruments — directly comparable to Scale Bio's Quantum Barcoding approach. Parse has actively litigated against Scale Bio over barcoding IP.
  • 10x Genomics: 10x Genomics is the dominant commercial single-cell analysis company offering the Chromium platform for single-cell RNA, ATAC, and multi-omic workflows. It is the most direct competitor to Scale Bio's QuantumScale kits and is also the announced acquirer of Scale Biosciences.
  • BD Biosciences (BD Rhapsody): BD Biosciences markets the Rhapsody single-cell analysis platform for transcriptomic and multi-omic applications, competing head-to-head with both 10x Genomics and Scale Bio in academic and pharma single-cell workflows.

Broad incumbents

  • Element Biosciences: Element Biosciences offers the AVITI sequencing platform as a lower-cost alternative to Illumina. As an alternative sequencer platform, Element is an indirect competitor to Scale Bio in shaping customers' choice of single-cell library preparation and sequencing stack.
  • Illumina: Illumina is the dominant sequencing platform provider whose NovaSeq and NextSeq instruments are the primary downstream readout for Scale Bio's kits. Illumina also offers its own single-cell and multi-omic library prep products, making it both a critical partner and a broad incumbent competitor.
  • Bio-Rad Laboratories (ddSEQ): Bio-Rad offers ddSEQ single-cell RNA sequencing solutions through partnership with Illumina, competing in academic and translational research single-cell workflows alongside Scale Bio and other droplet-based platforms.

Emerging players

  • Vizgen: Vizgen offers MERSCOPE spatial transcriptomics. Scale Bio and Vizgen have a documented integration partnership for combining Scale Bio's single-cell RNA with Vizgen's spatial analysis, positioning Vizgen as a complementary adjacent peer in the broader single-cell/spatial genomics market.
  • AtlasXomics: AtlasXomics provides single-cell ATAC-seq and multi-omic epigenomic profiling services, directly competing with Scale Bio's Single Cell Methylation Kit in the epigenomics research market.
  • Ultima Genomics: Ultima Genomics is a sequencing platform provider whose UG 100 instrument is compatible with Scale Bio's QuantumScale kits. The companies are co-collaborators in CZI's Billion Cells Project and the 100M Cell Challenge initiative.
  • Fluent Biosciences: Fluent Biosciences offers PIP-seq, a single-cell RNA sequencing technology using combinatorial barcoding that competes with Scale Bio's QuantumScale in the no-instrument, low-cost segment of the market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Scale Biosciences social profiles

Digital presence

Scale Biosciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Scale Biosciences leadership team

Management profile

Number of profiles

Profiles5 records

Scale Biosciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Scale Biosciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scale Biosciences

What does Scale Biosciences do?

Scale Biosciences develops and sells reagent kits and laboratory services for single cell genomic, transcriptomic, and epigenomic profiling, powered by its proprietary Quantum Barcoding technology. The portfolio includes the QuantumScale Single Cell RNA kit family (processing 168K to 4M cells per run), the Single Cell Methylation Kit for DNA methylation analysis, the ScalePlex sample multiplexing reagents, and the CRISPR Guide Enrichment Kit for pooled CRISPR screening at single cell resolution.

Is Scale Biosciences a public or private company?

Scale Biosciences is a private company. It is classified as unknown and is currently operating.

When was Scale Biosciences founded?

Scale Biosciences was founded in 2020. It employs 1 to 10 people.

Where is Scale Biosciences based?

Scale Biosciences is headquartered in San Diego, United States, in the North America region.

How does Scale Biosciences make money?

Five revenue lines are on record. Single Cell RNA Sequencing Kits are the primary driver. The others are single Cell Methylation Kits, scalePlex Fixation Kits, CRISPR Guide Enrichment Kits and services.

Who are Scale Biosciences's main competitors?

Direct peers on record are Parse Biosciences, 10x Genomics and BD Biosciences (BD Rhapsody). Broad incumbents are Element Biosciences, Illumina and Bio-Rad Laboratories (ddSEQ). Emerging players are Vizgen, AtlasXomics, Ultima Genomics and Fluent Biosciences.

Does Scale Biosciences have an API?

No public API is recorded for Scale Biosciences.

What industry is Scale Biosciences in?

Scale Biosciences's product category is Life Science Research Tools. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGANAF, Epigenomics & Chromatin Profiling Services. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AETOSWireParse Biosciences Invalidates Scale Biosciences (now 10x Genomics) PatentThe District Court for the District of Delaware granted Parse Biosciences' motion for summary judgment of invalidity for Scale Biosciences' patent 11,634,752, ruling the claims invalid for lack of written description and enablement. Parse, a single-cell sequencing provider, has raised over $100 million and is used by over 3,000 customers.Investing.comJury finds Parse Biosciences willfully infringed Scale patents By Investing.comA jury in Delaware's U.S. District Court ruled Parse Biosciences, now a Qiagen subsidiary, willfully infringed three patents exclusively licensed to Scale Biosciences, part of 10x Genomics, since 2025. The jury awarded 10x Genomics over $4.8 million in damages on a 14% royalty rate on Evercode Whole Transcriptome sales from February 2021 through June 30, 2026. 10x Genomics plans to seek enhanced damages, attorneys' fees and a permanent injunction.Investing.comJury finds Parse Biosciences willfully infringed Scale patents By Investing.comA jury in Delaware's U.S. District Court ruled Parse Biosciences, now a Qiagen subsidiary, willfully infringed three patents exclusively licensed to Scale Biosciences, part of 10x Genomics, on Evercode Whole Transcriptome products sold from February 2021 through June 30, 2026. The jury awarded 10x Genomics over $4.8 million at a 14% royalty rate and rejected Parse's validity challenges. 10x Genomics plans to seek enhanced damages, attorneys' fees and a permanent injunction.Stock Titan10x Genomics Wins Over $4.8M Patent Verdict Against ParseA jury in the U.S. District Court for the District of Delaware found Parse Biosciences, now a Qiagen subsidiary, willfully infringed three patents exclusively licensed to Scale Biosciences, part of 10x Genomics since 2025, and rejected Parse's validity challenges. The jury awarded 10x over $4.8 million in damages based on a 14% royalty rate on Evercode Whole Transcriptome sales from February 2021 through June 30, 2026. 10x will seek enhanced damages, attorneys' fees and a permanent injunction.openPR.comAnalysis of Key Market Segments Influencing the Methylmalonic Acidemia (MMA) MarketThe Business Research Company published an analysis projecting the global methylmalonic acidemia (MMA) market to reach $13.06 billion by 2030, growing at a compound annual growth rate of 5.6%, driven by advances in precision therapeutics, gene and enzyme replacement therapies, and increased rare disease funding. In January 2024, US biotechnology firm Scale Biosciences launched the Single Cell RNA Kit v1.1-Extended Throughput, a single cell analysis tool supporting processing of up to 500,000 cells per run to enhance transcriptomic research capabilities.openPR.comUS Single Cell Omics Market Size and Trends 2025-2034: Market Poised for Rapid Growth with USD 28.88 Billion Opportunity in Precision MedicineThe global single-cell omics market was valued at US$2.4 billion in 2022 and is projected to reach US$15.5 billion by 2032, a CAGR of 20.2%. Growth is driven by advancements in sequencing technologies and increasing investment in precision medicine. Key developments include 10x Genomics' acquisition of Scale Biosciences and Illumina's spatial multi-omics roadmap.SynBioBeta10x Genomics to Acquire Scale Biosciences10x Genomics has announced a definitive agreement to acquire Scale Biosciences, integrating the latter's scalable single cell analysis technologies into its Chromium platform. This strategic move aims to enhance the accessibility and affordability of single cell analysis for global researchers while advancing 10x's multi-year product roadmap.AInvest10x Genomics Sees Strong Growth with Q2 Results, Strategic Acquisition, and Optimistic Outlook10x Genomics reported Q2 2025 revenue of $172.9 million, up $27.3 million year-over-year, driven by a patent litigation settlement. The company agreed to acquire Scale Biosciences for $30 million plus contingent consideration and expects Q3 revenue of $140–144 million.FierceBiotech10x Genomics scoops up Scale Biosciences and its single-cell analysis kits10x Genomics has acquired Scale Biosciences for $30 million in upfront cash and stock to integrate its single-cell profiling solutions into the Chromium platform. Concurrently, 10x Genomics reported second-quarter revenue of $172.9 million, a figure significantly boosted by a $27.3 million patent litigation settlement with Bruker.Genengnews10x Genomics Scales Up, Agrees to Acquire Scale Biosciences10x Genomics has agreed to acquire Scale Biosciences for an upfront payment of $30 million in cash and stock, plus additional milestone-based payments. The acquisition aims to integrate Scale’s split-pool combinatorial barcoding technology into 10x’s Chromium portfolio to enhance single-cell experimentation capabilities. This move allows Scale’s technology to leverage 10x’s global market reach amid a challenging macroeconomic environment.